These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
722 related articles for article (PubMed ID: 28493389)
41. Transcathether aortic valve implantation with the new repositionable self-expandable Medtronic Evolut R vs. CoreValve system: evidence on the benefit of a meta-analytical approach. Kowalewski M; Gozdek M; Raffa GM; Słomka A; Zieliński K; Kubica J; Anisimowicz L; Kowalewski J; Landes U; Kornowski R; Lorusso R; Suwalski P J Cardiovasc Med (Hagerstown); 2019 Apr; 20(4):226-236. PubMed ID: 30829877 [TBL] [Abstract][Full Text] [Related]
42. First experience with the new generation Edwards Sapien 3 aortic bioprosthesis: procedural results and short term outcome. Murray MI; Geis N; Pleger ST; Kallenbach K; Katus HA; Bekeredjian R; Chorianopoulos E J Interv Cardiol; 2015 Feb; 28(1):109-16. PubMed ID: 25689554 [TBL] [Abstract][Full Text] [Related]
43. Prospective comparison between three TAVR devices: ACURATE neo vs. CoreValve vs. SAPIEN XT. A single heart team experience in patients with severe aortic stenosis. Jatene T; Castro-Filho A; Meneguz-Moreno RA; Siqueira DA; Abizaid AAC; Ramos AIO; Arrais M; Le Bihan DCS; Barretto RBM; Moreira AC; Sousa AGMR; Eduardo Sousa J Catheter Cardiovasc Interv; 2017 Jul; 90(1):139-146. PubMed ID: 28029207 [TBL] [Abstract][Full Text] [Related]
44. Outcome With the Repositionable and Retrievable Boston Scientific Lotus Valve Compared With the Balloon-Expandable Edwards Sapien 3 Valve in Patients Undergoing Transfemoral Aortic Valve Replacement. Seeger J; Gonska B; Rottbauer W; Wöhrle J Circ Cardiovasc Interv; 2017 Jun; 10(6):. PubMed ID: 28566290 [TBL] [Abstract][Full Text] [Related]
45. Transfemoral aortic valve implantation is more successful with the Edwards Sapien 3 compared with the Edwards XT for the treatment of symptomatic severe aortic stenosis. Gonska B; Seeger J; Junker A; Rodewald C; Trepte U; Scharnbeck D; Rottbauer W; Wöhrle J Arch Cardiovasc Dis; 2018; 111(8-9):470-479. PubMed ID: 29128473 [TBL] [Abstract][Full Text] [Related]
46. Pacemaker Implantation After Balloon- or Self-Expandable Transcatheter Aortic Valve Replacement in Patients With Aortic Stenosis. Bisson A; Bodin A; Herbert J; Lacour T; Saint Etienne C; Pierre B; Clementy N; Deharo P; Babuty D; Fauchier L J Am Heart Assoc; 2020 May; 9(9):e015896. PubMed ID: 32362220 [TBL] [Abstract][Full Text] [Related]
47. Thirty-day Outcome Following CoreValve Evolut R Transcatheter Aortic Valve Implantation: An All-comers Prospective Study. Perrin N; Roffi M; Frei A; Hachulla AL; Ellenberger C; Müller H; Cikirikcioglu M; Licker M; Noble S Rev Esp Cardiol (Engl Ed); 2017 Sep; 70(9):713-719. PubMed ID: 28034684 [TBL] [Abstract][Full Text] [Related]
50. Clinical outcome and paravalvular leakage of the new balloon-expandable Edwards Sapien 3 valve in comparison to its predecessor model (Edwards Sapien XT) in patients undergoing transfemoral aortic valve replacement. Bocksch W; Grossmann B; Geisler T; Steeg M; Droppa M; Jorbenadze R; Haap M; Gawaz M; Fateh-Moghadam S Catheter Cardiovasc Interv; 2016 Sep; 88(3):466-75. PubMed ID: 27184353 [TBL] [Abstract][Full Text] [Related]